Go Pro

OMNIQ (OMQS) Competitors

OMNIQ logo
$0.09 0.00 (0.00%)
As of 09/24/2026 09:30 AM Eastern

OMQS vs. CXAI, ZSPC, IFBD, LCFY, and ENTO

Should you buy OMNIQ stock or one of its competitors? OMNIQ's main competitors and comparable companies include CXApp (CXAI), zSpace (ZSPC), Infobird (IFBD), Locafy (LCFY), and Entero Therapeutics (ENTO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does OMNIQ compare to CXApp?

OMNIQ (NASDAQ:OMQS) and CXApp (NASDAQ:CXAI) are both small-cap technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

In the previous week, CXApp had 1 more articles in the media than OMNIQ. MarketBeat recorded 1 mentions for CXApp and 0 mentions for OMNIQ. CXApp's average media sentiment score of 1.79 beat OMNIQ's score of 0.00 indicating that CXApp is being referred to more favorably in the news media.

Company Overall Sentiment
OMNIQ Neutral
CXApp Very Positive

OMNIQ has a net margin of -34.33% compared to CXApp's net margin of -446.46%. OMNIQ's return on equity of 0.00% beat CXApp's return on equity.

Company Net Margins Return on Equity Return on Assets
OMNIQ-34.33% N/A -61.97%
CXApp -446.46%-135.04%-65.41%

CXApp has lower revenue, but higher earnings than OMNIQ. OMNIQ is trading at a lower price-to-earnings ratio than CXApp, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OMNIQ$81.19M0.02-$29.43M-$0.20N/A
CXApp$4.58M1.27-$13.47M-$26.00N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OMNIQ
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
CXApp
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

5.7% of OMNIQ shares are held by institutional investors. Comparatively, 14.4% of CXApp shares are held by institutional investors. 11.6% of OMNIQ shares are held by company insiders. Comparatively, 3.3% of CXApp shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

OMNIQ has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market. Comparatively, CXApp has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market.

Summary

OMNIQ beats CXApp on 8 of the 14 factors compared between the two stocks.

How does OMNIQ compare to zSpace?

OMNIQ (NASDAQ:OMQS) and zSpace (NASDAQ:ZSPC) are both small-cap technology companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

zSpace has a consensus target price of $75.00, indicating a potential upside of 50,747.46%. Given zSpace's stronger consensus rating and higher possible upside, analysts clearly believe zSpace is more favorable than OMNIQ.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OMNIQ
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
zSpace
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

5.7% of OMNIQ shares are owned by institutional investors. 11.6% of OMNIQ shares are owned by company insiders. Comparatively, 8.7% of zSpace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, zSpace had 1 more articles in the media than OMNIQ. MarketBeat recorded 1 mentions for zSpace and 0 mentions for OMNIQ. zSpace's average media sentiment score of 0.50 beat OMNIQ's score of 0.00 indicating that zSpace is being referred to more favorably in the news media.

Company Overall Sentiment
OMNIQ Neutral
zSpace Positive

OMNIQ has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market. Comparatively, zSpace has a beta of -1.41, indicating that its stock price is 241% less volatile than the broader market.

zSpace has lower revenue, but higher earnings than OMNIQ. OMNIQ is trading at a lower price-to-earnings ratio than zSpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OMNIQ$81.19M0.02-$29.43M-$0.20N/A
zSpace$27.86M0.20-$25.39M-$16.94N/A

OMNIQ has a net margin of -34.33% compared to zSpace's net margin of -91.13%.

Company Net Margins Return on Equity Return on Assets
OMNIQ-34.33% N/A -61.97%
zSpace -91.13%N/A -236.00%

Summary

OMNIQ and zSpace tied by winning 7 of the 14 factors compared between the two stocks.

How does OMNIQ compare to Infobird?

OMNIQ (NASDAQ:OMQS) and Infobird (NASDAQ:IFBD) are both small-cap technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OMNIQ
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Infobird
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

5.7% of OMNIQ shares are owned by institutional investors. Comparatively, 2.9% of Infobird shares are owned by institutional investors. 11.6% of OMNIQ shares are owned by company insiders. Comparatively, 35.5% of Infobird shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

OMNIQ has higher revenue and earnings than Infobird.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OMNIQ$81.19M0.02-$29.43M-$0.20N/A
Infobird$8.71M0.66-$57.19MN/AN/A

In the previous week, Infobird had 5 more articles in the media than OMNIQ. MarketBeat recorded 5 mentions for Infobird and 0 mentions for OMNIQ. Infobird's average media sentiment score of 0.64 beat OMNIQ's score of 0.00 indicating that Infobird is being referred to more favorably in the news media.

Company Overall Sentiment
OMNIQ Neutral
Infobird Positive

OMNIQ has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market. Comparatively, Infobird has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market.

Infobird has a net margin of 0.00% compared to OMNIQ's net margin of -34.33%.

Company Net Margins Return on Equity Return on Assets
OMNIQ-34.33% N/A -61.97%
Infobird N/A N/A N/A

Summary

Infobird beats OMNIQ on 8 of the 11 factors compared between the two stocks.

How does OMNIQ compare to Locafy?

OMNIQ (NASDAQ:OMQS) and Locafy (NASDAQ:LCFY) are both small-cap technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OMNIQ
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Locafy
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

5.7% of OMNIQ shares are owned by institutional investors. Comparatively, 0.0% of Locafy shares are owned by institutional investors. 11.6% of OMNIQ shares are owned by company insiders. Comparatively, 28.7% of Locafy shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

OMNIQ has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market. Comparatively, Locafy has a beta of 1.69, indicating that its share price is 69% more volatile than the broader market.

In the previous week, Locafy had 3 more articles in the media than OMNIQ. MarketBeat recorded 3 mentions for Locafy and 0 mentions for OMNIQ. Locafy's average media sentiment score of 0.26 beat OMNIQ's score of 0.00 indicating that Locafy is being referred to more favorably in the news media.

Company Overall Sentiment
OMNIQ Neutral
Locafy Neutral

Locafy has lower revenue, but higher earnings than OMNIQ. Locafy is trading at a lower price-to-earnings ratio than OMNIQ, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OMNIQ$81.19M0.02-$29.43M-$0.20N/A
Locafy$3.94M1.43-$2.79M-$0.89N/A

Locafy has a net margin of 0.00% compared to OMNIQ's net margin of -34.33%.

Company Net Margins Return on Equity Return on Assets
OMNIQ-34.33% N/A -61.97%
Locafy N/A N/A N/A

Summary

Locafy beats OMNIQ on 9 of the 13 factors compared between the two stocks.

How does OMNIQ compare to Entero Therapeutics?

OMNIQ (NASDAQ:OMQS) and Entero Therapeutics (NASDAQ:ENTO) are both small-cap technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OMNIQ
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Entero Therapeutics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Entero Therapeutics has lower revenue, but higher earnings than OMNIQ. Entero Therapeutics is trading at a lower price-to-earnings ratio than OMNIQ, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OMNIQ$81.19M0.02-$29.43M-$0.20N/A
Entero TherapeuticsN/AN/A-$18.06M-$1.69N/A

Entero Therapeutics has a net margin of 0.00% compared to OMNIQ's net margin of -34.33%. OMNIQ's return on equity of 0.00% beat Entero Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
OMNIQ-34.33% N/A -61.97%
Entero Therapeutics N/A -461.02%-14.72%

OMNIQ has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, Entero Therapeutics has a beta of 1.19, meaning that its stock price is 19% more volatile than the broader market.

5.7% of OMNIQ shares are held by institutional investors. Comparatively, 12.3% of Entero Therapeutics shares are held by institutional investors. 11.6% of OMNIQ shares are held by company insiders. Comparatively, 0.8% of Entero Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Entero Therapeutics' average media sentiment score of 0.75 beat OMNIQ's score of 0.00 indicating that Entero Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
OMNIQ Neutral
Entero Therapeutics Positive

Summary

OMNIQ and Entero Therapeutics tied by winning 6 of the 12 factors compared between the two stocks.

Get OMNIQ News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMQS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMQS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMQS vs. The Competition

MetricOMNIQSoftware IndustryTechnology SectorNASDAQ Exchange
Market Cap$1.39M$16.09B$31.16B$13.16B
Dividend YieldN/A3.42%2.74%12.57%
P/E Ratio-0.03142.1579.4425.84
Price / Sales0.021,283.57589.80110.94
Price / CashN/A47.5449.7052.76
Price / Book-0.038.777.976.33
Net Income-$29.43M$432.51M$702.31M$359.77M
7 Day PerformanceN/A0.76%1.36%-0.03%
1 Month PerformanceN/A-2.72%-1.61%-3.96%
1 Year PerformanceN/A-0.15%179.18%6.32%

OMNIQ Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OMQS
OMNIQ
N/A$0.09
flat
N/A+8.2%$1.39M$81.19MN/A190
CXAI
CXApp
0.7622 of 5 stars
$2.49
-1.6%
N/A-93.2%$5.91M$4.58MN/A2
ZSPC
zSpace
1.1925 of 5 stars
$0.16
-5.9%
$75.00
+48,193.6%
-99.5%$5.76M$27.86MN/A70
IFBD
Infobird
0.779 of 5 stars
$0.93
-6.1%
N/A-12.4%$5.40M$8.71MN/A390
LCFY
Locafy
0.3311 of 5 stars
$2.30
-2.3%
N/A-63.6%$5.28M$3.94MN/A50

Related Companies and Tools


This page (NASDAQ:OMQS) was last updated on 9/25/2026 by MarketBeat.com Staff.
From Our Partners